BFRI

Biofrontera Inc. is a biopharmaceutical company based in Woburn, Massachusetts, focused on the development and commercialization of advanced dermatological therapies aimed at treating a range of skin conditions. With a strong emphasis on leveraging proprietary technologies, Biofrontera seeks to improve treatment efficacy and patient outcomes within the U.S. dermatology market. The company is dedicated to enhancing dermatological care and is strategically expanding its product portfolio to establish itself as a leading player in the industry.